Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 163 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Hematologic Malignancy, Solid Tumor, Advanced Malignancies Phase3 Belgium
Italy
Netherlands
United Kingdom
United States
View all

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Relapsing Multiple Sclerosis (RMS) Phase3 United States

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Chagas Disease Phase2 Argentina
Brazil
Colombia
United States
View all

Modifying PEST for Psoriatic Arthritis Screening

Plaque Psoriasis, Psoriatic Arthritis Na Canada

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

Follicular Lymphoma (FL) Phase3 Australia
Austria
Canada
Czechia
Hungary
Poland
Romania
Singapore
Slovakia
South Korea
Spain
Taiwan
United States
View all

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

Hidradenitis Suppurativa Russia

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Alzheimer's Disease Phase2 Canada
United Kingdom
United States

A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation

HR+HER2- Advanced Breast Cancer Russia

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase1, Phase2 France
Japan
United States

Long-term Follow up Local Registry Study of Kymriah in South Korea

B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma South Korea